Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2022

16-10-2021 | Gastric Cancer | Original Article

MicroRNA-574-3p Regulates HIF-α Isoforms Promoting Gastric Cancer Epithelial-Mesenchymal Transition via Targeting CUL2

Authors: Zhiwu Ji, Xingquan Wang, Yingli Liu, Min Zhong, Jiabin Sun, Jincai Shang

Published in: Digestive Diseases and Sciences | Issue 8/2022

Login to get access

Abstract

Background

Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. MicroRNAs (miRNAs) have been widely validated as potential biomarkers for cancer treatment and diagnosis.

Aims

This paper intends to study the effect and specific mechanism of miR-574-3p/CUL2 axis in GC.

Methods

The miR-574-3p expression in GC tissues and cell lines was analyzed by reverse transcription polymerase chain reaction (RT-PCR). GC cell (N87) proliferation, migration and invasion were determined by the Brdu assay and Transwell assay, respectively. The tumor xenotransplantation model was established in vivo to test the effect of miR-574-3p or Cullin 2 (CUL2) on tumor growth. The relationship between miR-574-3p and CUL2 was predicated by bioinformatic analysis and verified by dual-luciferase reporter assay and RIP experiment. The expression of CUL2, hypoxia-induced transcription factor-1α (HIF-1α) as well as E-cadherin, Snail and Vimentin was monitored by western blot and immunohistochemistry.

Results

miR-574-3p was overexpressed in GC tissues and cells. Forced upregulation of miR-574-3p enhanced proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) of GC cells (N87), while downregulation of miR-574-3p resulted in reverse effects. Additionally, miR-574-3p promoted N87 cells growth and EMT in vivo. CUL2 was negatively regulated by miR-574-3p in N87 cells, and upregulation of CUL2 repressed the malignant behaviors of N87 cells. Moreover, CUL2 directly interacted with HIF-1α and suppressed HIF-1α expression both in vitro and in vivo.

Conclusions

miR-574-3p targeted CUL2 to upregulate HIF-1α, thus facilitating the progression of GC.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.CrossRef Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.CrossRef
2.
go back to reference Tirino G, Pompella L, Petrillo A et al. What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives. Int J Mol Sci. 2018;19:2659.CrossRef Tirino G, Pompella L, Petrillo A et al. What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives. Int J Mol Sci. 2018;19:2659.CrossRef
3.
go back to reference Lujambio A, Lowe SW. The Microcosmos of Cancer. Nature. 2012;482:347–355.CrossRef Lujambio A, Lowe SW. The Microcosmos of Cancer. Nature. 2012;482:347–355.CrossRef
4.
go back to reference Hu SB, Zheng QC, Wu HS et al. miR-532 Promoted Gastric Cancer Migration and Invasion by Targeting NKD1. Life Sci. 2017;177:15–19.CrossRef Hu SB, Zheng QC, Wu HS et al. miR-532 Promoted Gastric Cancer Migration and Invasion by Targeting NKD1. Life Sci. 2017;177:15–19.CrossRef
5.
go back to reference Lu MD, Huang YP, Sun WJ et al. miR-135b-5p Promotes Gastric Cancer Progression by Targeting CMTM3. Int J Oncol. 2018;52:589–598.PubMed Lu MD, Huang YP, Sun WJ et al. miR-135b-5p Promotes Gastric Cancer Progression by Targeting CMTM3. Int J Oncol. 2018;52:589–598.PubMed
6.
go back to reference Jin LL, Zhang SJ, Lu GX, et al. miR-574–3p Inhibits Proliferation and Invasion in Esophageal Cancer by Targeting FAM3C and MAPK1. Kaohsiung J Med Sci. 2019. Jin LL, Zhang SJ, Lu GX, et al. miR-574–3p Inhibits Proliferation and Invasion in Esophageal Cancer by Targeting FAM3C and MAPK1. Kaohsiung J Med Sci. 2019.
7.
go back to reference Zheng J, Zhou Y, Li XJ et al. miR-574-3p Exerts as a Tumor Suppressor in Ovarian Cancer Through Inhibiting MMP3 Expression. Eur Rev Med Pharmacol Sci. 2019;23:6839–6848.PubMed Zheng J, Zhou Y, Li XJ et al. miR-574-3p Exerts as a Tumor Suppressor in Ovarian Cancer Through Inhibiting MMP3 Expression. Eur Rev Med Pharmacol Sci. 2019;23:6839–6848.PubMed
8.
go back to reference Zhang RW, Wang MQ, Sui PC et al. Upregulation of microRNA-574-3p in a Human Gastric Cancer Cell Line AGS by TGF-β1. Gene. 2017;605:63–69.CrossRef Zhang RW, Wang MQ, Sui PC et al. Upregulation of microRNA-574-3p in a Human Gastric Cancer Cell Line AGS by TGF-β1. Gene. 2017;605:63–69.CrossRef
9.
go back to reference Kamura T, Maenaka K, Kotoshiba S et al. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 2004;18:3055–3065.CrossRef Kamura T, Maenaka K, Kotoshiba S et al. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 2004;18:3055–3065.CrossRef
10.
go back to reference Xu JF, Fang YF, Wang XY et al. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis. Oncotarget. 2016;7:31520–31533.CrossRef Xu JF, Fang YF, Wang XY et al. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis. Oncotarget. 2016;7:31520–31533.CrossRef
11.
go back to reference Liu AY, ZHang SZ, Shen YW, et al. Association of mRNA Expression Levels of Cullin Family Members With Prognosis in Breast Cancer: An Online Database Analysis. Medicine (Baltimore). 2019; 98:e16625. Liu AY, ZHang SZ, Shen YW, et al. Association of mRNA Expression Levels of Cullin Family Members With Prognosis in Breast Cancer: An Online Database Analysis. Medicine (Baltimore). 2019; 98:e16625.
12.
go back to reference Chen P, Yao GD. The Role of Cullin Proteins in Gastric Cancer. Tumour Biol. 2016;37:29–37.CrossRef Chen P, Yao GD. The Role of Cullin Proteins in Gastric Cancer. Tumour Biol. 2016;37:29–37.CrossRef
13.
go back to reference Poon E, Harris A, Ashcroft M. Targeting the Hypoxia-Inducible Factor (HIF) Pathway in Cancer. Expert Rev Mol Med. 2009;11:e26. Poon E, Harris A, Ashcroft M. Targeting the Hypoxia-Inducible Factor (HIF) Pathway in Cancer. Expert Rev Mol Med. 2009;11:e26.
14.
go back to reference Krieg M, Haas R, Brauch H et al. Up-regulation of Hypoxia-Inducible Factors HIF-1alpha and HIF-2alpha Under Normoxic Conditions in Renal Carcinoma Cells by Von Hippel-Lindau Tumor Suppressor Gene Loss of Function. Oncogene. 2000;19:5435–5443.CrossRef Krieg M, Haas R, Brauch H et al. Up-regulation of Hypoxia-Inducible Factors HIF-1alpha and HIF-2alpha Under Normoxic Conditions in Renal Carcinoma Cells by Von Hippel-Lindau Tumor Suppressor Gene Loss of Function. Oncogene. 2000;19:5435–5443.CrossRef
15.
go back to reference Ghosh G, Subramanian IV, Adhikari N et al. Hypoxia-induced microRNA-424 Expression in Human Endothelial Cells Regulates HIF-α Isoforms and Promotes Angiogenesis. J Clin Invest. 2010;120:4141–4154.CrossRef Ghosh G, Subramanian IV, Adhikari N et al. Hypoxia-induced microRNA-424 Expression in Human Endothelial Cells Regulates HIF-α Isoforms and Promotes Angiogenesis. J Clin Invest. 2010;120:4141–4154.CrossRef
16.
go back to reference Wang Q, Zhang F, Lei Y, Liu P, Liu C, Tao Y. microRNA-322/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2/HIF-1α pathway. Life Sci. 2021;266:118819. Wang Q, Zhang F, Lei Y, Liu P, Liu C, Tao Y. microRNA-322/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2/HIF-1α pathway. Life Sci. 2021;266:118819.
17.
go back to reference McLean MH, El-Omar EM. Genetics of Gastric Cancer. Nat Rev Gastroenterol Hepatol. 2014;11:664–674.CrossRef McLean MH, El-Omar EM. Genetics of Gastric Cancer. Nat Rev Gastroenterol Hepatol. 2014;11:664–674.CrossRef
18.
go back to reference Wu ZH, Lin C, Liu CC et al. MiR-616-3p Promotes Angiogenesis and EMT in Gastric Cancer via the PTEN/AKT/mTOR Pathway. Biochem Biophys Res Commun. 2018;501:1068–1073.CrossRef Wu ZH, Lin C, Liu CC et al. MiR-616-3p Promotes Angiogenesis and EMT in Gastric Cancer via the PTEN/AKT/mTOR Pathway. Biochem Biophys Res Commun. 2018;501:1068–1073.CrossRef
19.
go back to reference Li Y, Yan XL, Shi JJ et al. Aberrantly Expressed miR-188-5p Promotes Gastric Cancer Metastasis by Activating Wnt/β-catenin Signaling. BMC Cancer. 2019;19:505.CrossRef Li Y, Yan XL, Shi JJ et al. Aberrantly Expressed miR-188-5p Promotes Gastric Cancer Metastasis by Activating Wnt/β-catenin Signaling. BMC Cancer. 2019;19:505.CrossRef
20.
go back to reference Yang X, Wang M, Lin B, et al. miR-487a Promotes Progression of Gastric Cancer by Targeting TIA1 Biochimie. 2018;154:119–126. Yang X, Wang M, Lin B, et al. miR-487a Promotes Progression of Gastric Cancer by Targeting TIA1 Biochimie. 2018;154:119–126.
21.
go back to reference Su YY, Ni ZH, Wang GQ et al. Aberrant Expression of microRNAs in Gastric Cancer and Biological Significance of miR-574-3p. Int Immunopharmacol. 2012;13:468–475.CrossRef Su YY, Ni ZH, Wang GQ et al. Aberrant Expression of microRNAs in Gastric Cancer and Biological Significance of miR-574-3p. Int Immunopharmacol. 2012;13:468–475.CrossRef
22.
go back to reference Hwang J, Min BH, Jang J et al. MicroRNA Expression Profiles in Gastric Carcinogenesis. Sci Rep. 2018;8:14393.CrossRef Hwang J, Min BH, Jang J et al. MicroRNA Expression Profiles in Gastric Carcinogenesis. Sci Rep. 2018;8:14393.CrossRef
23.
go back to reference Zhang ZY, Pi JN, Zou DL et al. microRNA Arm-Imbalance in Part From Complementary Targets Mediated Decay Promotes Gastric Cancer Progression. Nat Commun. 2019;10:4397.CrossRef Zhang ZY, Pi JN, Zou DL et al. microRNA Arm-Imbalance in Part From Complementary Targets Mediated Decay Promotes Gastric Cancer Progression. Nat Commun. 2019;10:4397.CrossRef
24.
go back to reference Wang MQ, Zhang RW, Zhang Shu, et al. MicroRNA-574-3p Regulates Epithelial Mesenchymal Transition and Cisplatin Resistance via Targeting ZEB1 in Human Gastric Carcinoma Cells. Gene. 2019;700:110-119. Wang MQ, Zhang RW, Zhang Shu, et al. MicroRNA-574-3p Regulates Epithelial Mesenchymal Transition and Cisplatin Resistance via Targeting ZEB1 in Human Gastric Carcinoma Cells. Gene. 2019;700:110-119.
26.
go back to reference Xu H, Liu X, Zhou J, Chen X, Zhao J. miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway. Oncol Lett. 2016;12:5247–5253.CrossRef Xu H, Liu X, Zhou J, Chen X, Zhao J. miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway. Oncol Lett. 2016;12:5247–5253.CrossRef
27.
go back to reference Maeda Y, Suzuki T, Pan XF et al. CUL2 Is Required for the Activity of Hypoxia-Inducible Factor and Vasculogenesis. J Biol Chem. 2008;283:16084–16092.CrossRef Maeda Y, Suzuki T, Pan XF et al. CUL2 Is Required for the Activity of Hypoxia-Inducible Factor and Vasculogenesis. J Biol Chem. 2008;283:16084–16092.CrossRef
28.
go back to reference Westrich JA, Warren CJ, Klausner MJ et al. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation. J Virol. 2018;92:e01318-e1417.CrossRef Westrich JA, Warren CJ, Klausner MJ et al. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation. J Virol. 2018;92:e01318-e1417.CrossRef
29.
go back to reference Wu QY, Zhu YY, Liu Y et al. CUEDC2, a Novel Interacting Partner of the SOCS1 Protein, Plays Important Roles in the Leukaemogenesis of Acute Myeloid Leukaemia. Cell Death Dis. 2018;9:774.CrossRef Wu QY, Zhu YY, Liu Y et al. CUEDC2, a Novel Interacting Partner of the SOCS1 Protein, Plays Important Roles in the Leukaemogenesis of Acute Myeloid Leukaemia. Cell Death Dis. 2018;9:774.CrossRef
30.
go back to reference Meng J, Chen S, Han JX et al. Twist1 Regulates Vimentin Through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Res. 2018;78:4150–4162.CrossRef Meng J, Chen S, Han JX et al. Twist1 Regulates Vimentin Through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Res. 2018;78:4150–4162.CrossRef
31.
go back to reference Lin MC, Lin JJ, Hsu CL et al. GATA3 Interacts With and Stabilizes HIF-1α to Enhance Cancer Cell Invasiveness. Oncogene. 2017;36:4243–4252.CrossRef Lin MC, Lin JJ, Hsu CL et al. GATA3 Interacts With and Stabilizes HIF-1α to Enhance Cancer Cell Invasiveness. Oncogene. 2017;36:4243–4252.CrossRef
32.
go back to reference Bai CG, Liu XH, Zheng JM. FoxM1 Is Regulated by Both HIF-1α and HIF-2α and Contributes to Gastrointestinal Stromal Tumor Progression. Gastric Cancer. 2019;22:91–103.CrossRef Bai CG, Liu XH, Zheng JM. FoxM1 Is Regulated by Both HIF-1α and HIF-2α and Contributes to Gastrointestinal Stromal Tumor Progression. Gastric Cancer. 2019;22:91–103.CrossRef
33.
go back to reference Rohwer N, Lobitz S, Daskalow K et al. HIF-1alpha Determines the Metastatic Potential of Gastric Cancer Cells. Br J Cancer. 2009;100:772–781.CrossRef Rohwer N, Lobitz S, Daskalow K et al. HIF-1alpha Determines the Metastatic Potential of Gastric Cancer Cells. Br J Cancer. 2009;100:772–781.CrossRef
34.
go back to reference Tsai CY, Wang CS, Tsai MM et al. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis. Clin Cancer Res. 2014;20:2276–2288.CrossRef Tsai CY, Wang CS, Tsai MM et al. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis. Clin Cancer Res. 2014;20:2276–2288.CrossRef
Metadata
Title
MicroRNA-574-3p Regulates HIF-α Isoforms Promoting Gastric Cancer Epithelial-Mesenchymal Transition via Targeting CUL2
Authors
Zhiwu Ji
Xingquan Wang
Yingli Liu
Min Zhong
Jiabin Sun
Jincai Shang
Publication date
16-10-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07263-0

Other articles of this Issue 8/2022

Digestive Diseases and Sciences 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.